Pharmacist Sentenced To 78 Months In Prison For Attempting To Weaponize Deadly Toxins And Possessing Narcotics Manufacturing Equipment
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Pharmacist Sentenced To 78 Months In Prison For Attempting To Weaponize Deadly Toxins And Possessing Narcotics Manufacturing Equipment

Pharmacist Sentenced To 78 Months In Prison For Attempting To Weaponize Deadly Toxins And Possessing Narcotics Manufacturing Equipment

January 30, 2015
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kenneth M. Heino
Phone Number: (571) 362-6616

TRENTON, N.J. - Carl J. Kotowski, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division and Paul J. Fishman, U. S. Attorney for the District of New Jersey, announced a licensed pharmacist was sentenced today to 78 months in prison for attempting to weaponize the lethal toxins Ricin and Abrin and for possessing a prohibited flask intending to use it to manufacture illegal narcotics.
 
Jordan S. Gonzalez, 34, of New York, formerly of Jersey City, New Jersey, previously pleaded guilty before U.S. District Judge Mary L. Cooper to an information charging him with the offenses.
 
“The sentence imposed today on Jordan Gonzalez is an appropriate response to his efforts to manufacture and deploy toxins as deadly weapons,” U.S. Attorney Fishman said. “He was preparing for a violent confrontation that fortunately never occurred because the excellent response by our law enforcement partners stopped him before anyone was hurt.”

“Jordan Gonzalez had in his possession the ingredients and equipment necessary to manufacture dangerous biological toxins and explosives, as well as, a cache of weapons and ammunition,” FBI Acting Special Agent in Charge Eric Welling said. “Due to the tireless efforts of the FBI Joint Terrorism Task Force and the Drug Enforcement Administration, the imminent threat posed by Gonzalez did not become a reality. Prevention is the FBI’s priority, so I would like to remind the citizens of New Jersey to remain vigilant and contact the FBI or their nearest law enforcement department if they see or hear anything suspicious.”

“Mr. Gonzalez’ sentencing sends a clear message that attempting to produce weapons of mass destruction cannot be tolerated,” Carl J. Kotowski, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, said. “The dedicated men and women of DEA will continue to work tirelessly to keep criminals such as Mr. Gonzalez from being a threat to society.”

According documents filed in this case and statements made in court:

From September 18, 2011, through March 19, 2013, Gonzalez purchased thousands of seeds containing Ricin and Abrin, and materials to extract and administer those toxins to others, including filtering equipment, respirators and glass vials. Even small doses of Ricin and Abrin are lethal to humans if ingested, inhaled or injected - causing death within 36 to 72 hours from the time of exposure. There are no known antidotes.
 
Gonzalez also obtained conventional weapons, such as crossbows, spraying devices, and other items to deliver the toxins. He admitted he attempted to make these toxins in preparation for future confrontations with others. Gonzalez also obtained firearms, body armor, and precursor materials for the manufacture of military-grade explosives and improvised explosive devices. Gonzalez made the purchases through an online marketplace through which third-party vendors in the United States and abroad sell products to members of the public. Gonzalez learned how to extract toxins from the seeds and about methods to administer them to other persons from manuals he acquired. He also acquired manuals for making improvised explosive devices and synthesizing explosive compounds.
 
On November 8, 2013, while living in Manhattan, Gonzalez purchased one kilogram of sodium azide, a toxic, gas-forming compound that can explode at high temperatures and is lethal if ingested or absorbed through the skin. Law enforcement officers intercepted the delivery during the investigation.
 
On November 14, 2013, Gonzalez was arrested in Jersey City and search warrants were executed at three locations he used: apartments in Manhattan and Jersey City and a storage unit in Jersey City. Collectively, material collected through the searches included thousands of seeds containing Ricin and Abrin; explosive precursor chemicals; manuals related to toxins, explosives and improvised explosive devices; approximately 1,000 rounds of ammunition, handguns, components for assault rifles, and high-capacity magazines; a bulletproof vest; and books and documents related to the collapse of social order and techniques for surviving in a lawless environment.
 
Gonzalez also acquired manuals for synthesizing controlled substances, including (MDA) and (MDMA), also known as “ecstasy.” He bought and had delivered to the Jersey City apartment a three-neck round-bottom flask, gel capsules and an encapsulating machine, as well as precursor chemicals used in the manufacture of MDA and MDMA. Possession of that type of flask is prohibited if intended for use in the manufacturing of controlled substances.
 
In addition to the prison term, Judge Cooper sentenced Gonzalez to five years of supervised release.
 
U.S. Attorney Fishman credited special agents of the DEA, under the direction of Special Agent in Charge Kotowski in New Jersey; FBI, under the direction of Acting Special Agent in Charge Welling in Newark, NJ with the investigation leading to today’s sentencing. He also thanked members of FBI Newark’s Joint Terrorism Task Force; FBI’s New York Office and Weapons of Mass Destruction Directorate and Laboratory Division; DEA’s New York Division; and the New Jersey Office of Homeland Security and Preparedness for their work on the case; as well as the police and fire departments of Jersey City and the city of New York, as well as the New Jersey State Police for their assistance.
 

The government is represented by Assistant United States Attorneys L. Judson Welle and Francisco J. Navarro of the U.S. Attorney’s Office National Security Unit in Newark. Valuable support was provided by attorneys of the Department of Justice’s National Security Division - Counterterrorism Section.
Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Towanda Thorne-James Special Agent in Charge - New Jersey
@DEANewJerseyDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster